Does sermorelin cause hair loss? Evidence, other causes and next steps
The sources reviewed here do not establish a reliable rate of sermorelin-caused hair loss or prove that sermorelin regrows hair. New shedding deserves an assessment of the timeline, pattern, other medicines and possible underlying causes. A change after starting treatment is information for the clinician, not proof of cause or a reason to invent a treatment adjustment.
A symptom timeline is useful; it is not a diagnosis
If you notice shedding after starting a treatment, write down when it began and what else changed. Include the preparation, any added ingredients, other prescriptions, supplements and recent illnesses or changes in weight. This gives the clinician a more useful record than a message saying only that a peptide must be responsible.
Our side-effects guide examines what sellers disclose, while the broader safety guide explains why an individual assessment matters. A symptom occurring after a purchase does not establish that the purchase caused it. Equally, the absence of a prominent warning on a sales page does not prove that a concern should be dismissed without considering your circumstances.
There are several different kinds of hair loss
The American Academy of Dermatology identifies causes that include hereditary loss, illness or other stressors, thyroid disease, nutritional deficiencies, scalp conditions and some medicines. The pattern and timing help determine what needs evaluation. More than one cause can occur in the same person, so a single reassuring hormone number may leave the actual question unresolved.
Describe whether the change is diffuse shedding, a widening part, a receding hairline, patchy loss, breakage or a scalp problem. These descriptions do not diagnose the cause, but they help the professional direct the assessment. Ask whether examination by a dermatologist is appropriate instead of assuming every form of hair loss belongs in a generic hormone-optimization plan.[1]
What a growth-factor finding does not prove
A 2018 laboratory study found that stimulating an olfactory receptor in human hair follicles grown outside the body affected growth and IGF-1 signaling. It used a synthetic sandalwood odorant, not sermorelin treatment in patients. That result is a research finding about a specific experimental model, not evidence that raising a person’s circulating IGF-1 will reverse their hair loss.
The reverse inference is also unsupported: a relationship involving a growth factor cannot by itself establish that sermorelin causes shedding. Our IGF-1 guide explains why a blood marker is not a general outcome score. Ask for a study matching the actual medicine, people and hair outcome before accepting either a regrowth promise or a claim about the cause of a new symptom.[2]
A clinician may need more than a wellness laboratory panel
The Academy describes a cause-based evaluation that can include medical history, scalp and hair examination, and additional testing when indicated. Some people need a blood test or scalp biopsy; this is decided from the clinical assessment, not from a universal panel sold with a subscription. The useful question is what information would change the diagnosis or treatment recommendation.
Bring the full laboratory report if testing has already been done, rather than selecting a single highlighted value. Also mention hormone treatment from another practice. Our testosterone guide distinguishes separate hormone decisions; it does not identify which medicine caused hair loss in an individual. Coordinated records are more useful than asking two services to assess different fragments of the same history.[3]
| Observation to record | Why it helps the assessment |
|---|---|
| When the change began | Allows comparison with medicines, illness and other events |
| Pattern and scalp symptoms | Helps distinguish questions that need examination |
| Complete medication and supplement list | Avoids focusing only on the most recent product |
| Prior photographs under similar conditions | Provides context without proving a cause |
Evidence summarized from the linked sources in this section; this is not a head-to-head treatment trial.
Do not replace assessment with a supplement or a self-selected change
If you suspect a medicine is involved, contact the clinician who prescribed it. The Academy advises discussing suspected medication-related hair loss before stopping treatment, because abruptly stopping some medicines can cause health problems. The response depends on the actual prescription and reason it was given; this guide does not recommend stopping or continuing sermorelin in your individual case.
Similarly, adding a product promoted for hair growth can introduce another unknown without clarifying the cause. Ask whether there is an identified problem that the proposed treatment addresses and what evidence supports it. Keep a record of any change recommended by the treating professional so the subsequent assessment is based on a clear timeline.[1]
Judge regrowth claims by the outcome actually measured
A testimonial can describe an experience without proving that the newest medicine produced it. Lighting, hairstyle, hair length, concurrent treatments and the interval between photographs can affect a comparison. Our before-and-after guide explains why a personal account and a controlled study answer different questions. A positive story should not make the clinic skip an assessment of the cause.
Ask what improvement would be expected from the diagnosis-specific plan and how it will be reviewed. That conversation can involve a dermatologist or the prescriber managing a suspected medication issue. The aim is a clear explanation and appropriate care, rather than selecting whichever peptide advertisement promises the thickest hair or treating an online absence of evidence as a guaranteed answer for you.
Related reading
4 of 99 sermorelin sellers, showing different ways treatment is priced. Each review lists its source date.
Partner links can earn us a commission. How we’re funded.
Narrow this board
Showing all 4 sellers.
EmbodyPartner
$99 per month
a recurring rate
70/100 disclosure score
sermorelin injections; dose and vial size not stated
System LabsPartner
$89 first month
an introductory offer
65/100 disclosure score
page labels the supply as quarterly, 9 mg
CoreAge RxPartner
$99 per month
a starting price
45/100 disclosure score
dose not stated
Lavender Sky Health
$199 per 15 mg supply
a prepaid total
75/100 disclosure score
Red Rock Pharmacy injectable sermorelin, 15 mg; consultation extra
Sellers that pay us a commission come first in their group, identified by a Partner badge. That position is the only thing paying us buys. Below it, each group is ordered by what each seller states about its own figure: the kind of price first, then the figure itself. The price, the dose, the score and the review read the same either way. Compare the complete directory on compare sermorelin sellers. 1 of these 4 sellers names the pharmacy that compounds its sermorelin — Lavender Sky Health (Red Rock Pharmacy (15 mg injectable option)). A pharmacy named on a seller’s GLP-1 pages does not count: it says nothing about who makes this drug.